bioMerieux S.A. | Income Statement
Fiscal year is January-December. All values EUR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,588
1,698
1,965
2,103
2,288
2,421
Cost of Goods Sold (COGS) incl. D&A
763
870
994
1,021
1,095
1,137
Gross Income
825
828
971
1,082
1,194
1,285
SG&A Expense
590
658
769
841
908
972
EBIT
234
-
204
242
287
314
Unusual Expense
18
15
49
11
8
-
Non Operating Income/Expense
9
16
14
22
7
2
Interest Expense
4
15
17
17
16
17
Pretax Income
225
160
154
238
271
297
Income Tax
60
24
43
59
33
41
Equity in Affiliates
-
-
-
-
-
-
Consolidated Net Income
165
136
110
179
238
256
Net Income
164
135
111
179
238
257
Net Income After Extraordinaries
164
135
111
179
238
257
Net Income Available to Common
164
135
111
179
238
257
EPS (Basic)
1.39
1.14
0.93
1.51
2.02
2.18
Basic Shares Outstanding
118
118
118
118
118
118
EPS (Diluted)
1.39
1.14
0.93
1.51
2.02
2.17
Diluted Shares Outstanding
118
118
118
118
118
118
EBITDA
329
288
343
404
446
490
Other Operating Expense
-
1
2
1
2
2
Non-Operating Interest Income
3
2
2
2
1
1
Minority Interest Expense
-
1
1
-
1
1
About bioMerieux
View Profile